Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Midline Involvement as a Risk Factor for Vulvar Cancer Recurrence

  • Stankevica, Jekaterina (Department of Gynecology and Obstetrics of Riga Stradins University) ;
  • Macuks, Ronalds (Department of Gynecology and Obstetrics of Riga Stradins University) ;
  • Baidekalna, Ieva (Department of Gynecology and Obstetrics of Riga Stradins University) ;
  • Donina, Simona (Department of Immunology of Riga Eastern Clinical University Hospital Riga)
  • Published : 2012.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This observational study was to identify risk factors for vulvar cancer recurrence. Materials and Methods: In the study 107 patients with primary vulvar cancer were analyzed. Surgical treatment consisted of radical excision of the primary tumor in combination with unilateral or bilateral superficial and deep inguinofemoral lymphadenectomy through separate incisions. Patients with deeper tumor invasion >1 mm or wider than 2 cm and/or groin lymphnode metastases were referred for adjuvant radiotherapy. Those with large privary vulvar tumors received neoadjuvant radiotherapy of 30Gy followed by surgical treatment and adjuvant radiotherapy. Results: Most of patients had only primary radiotherapy to the vulva and inguinal lymph nodes and only 34.5% of patients were eligible for surgical treatment. In 5 year follow-up period 25.2% (27) patients were alive without the disease, 15.0% (16) were alive with the disease and 59.8% (64) were dead. 60.7% (65) patients experienced local recurrence and 2.8% (3) patients had distant metastases. Median survival for patients without recurrent disease was $38.9{\pm}3.2$ months and $36.0{\pm}2.6$ months with no statistically significant difference. Patients with early stage vulvar cancer had longer mean survival rates-for stage I $53.1{\pm}3.4$ months, $38.4{\pm}4.4$ months for stage II and $33.4{\pm}2.6$ and $15.6{\pm}5.2$ months for patients with stage III and stage IV vulvar cancer, respectively. The only signifficant prognostic factor predicting vulvar cancer recurrence was involvement of the midline. Conclusions: Patients having midline involvement of vulvar cancer has lower recurrence risk, probably because of receiving more aggressive treatment. There is a tendency for lower vulvar cancer recurrence risk for patients over 70 years of age and patients who are receiving radiotherapy as an only treatment without surgery, but tendency for higher risk of recurrence in patients with multifocal vulvar cancer.

Keywords

References

  1. Andreasson B, Nyboe J (1985). Value of prognostic parameters in squamous cell carcinoma of the vulva. Gynecol Oncol, 22, 341-51. https://doi.org/10.1016/0090-8258(85)90049-6
  2. Bell JG, Lea JS, Reid GC (2000). Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol, 77, 314-8. https://doi.org/10.1006/gyno.2000.5790
  3. Burger MP, Hollema H, Emanuels AG, et al (1995). The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol, 57, 327-34. https://doi.org/10.1006/gyno.1995.1151
  4. Chan JK, Sugiyama V, Pham H, et al (2007). Margin distance and other clinicopathologic prognostic factors in vulvar carcinoma: A multivariate analysis. Gynecol Oncol, 104, 636-41. https://doi.org/10.1016/j.ygyno.2006.10.004
  5. Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR (2006). Old and new perspectives in the management of highrisk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol, 60, 227-41. https://doi.org/10.1016/j.critrevonc.2006.06.009
  6. Gonzalez Bosquet J, Magrina JF, Gaffey TA, et al (2005). Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol, 97, 828-33. https://doi.org/10.1016/j.ygyno.2005.03.006
  7. Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG (1983). Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol, 61, 408-12.
  8. Hampl M, Kueppers V, Bender HG (2009). Single large inguinal lymph node metastasis in human papillomavirus-induced early invasive vulvar cancer of the anterior fourchette in two young women. Gynecol Obstet Invest, 67, 42-5. https://doi.org/10.1159/000159178
  9. Hefler L, Obermair A, Tempfer C, et al (1999). Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Int J Cancer, 84, 299-303. https://doi.org/10.1002/(SICI)1097-0215(19990621)84:3<299::AID-IJC17>3.0.CO;2-K
  10. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012.
  11. Iversen T, Aalders JG, Christensen A, Kolstad P (1980). Squamous cell carcinoma of the vulva: A review of 424 patients, 1956-1974. Gynecol Oncol, 9, 271-9. https://doi.org/10.1016/0090-8258(80)90038-4
  12. Kelley 3rd JL, Burke TW, Tornos C, et al (1992). Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol, 44, 240-4. https://doi.org/10.1016/0090-8258(92)90050-S
  13. Lataifeh I, Carraro Nascimento M, Nicklin JL, et al (2004). Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol, 95, 701-5. https://doi.org/10.1016/j.ygyno.2004.08.015
  14. Magrina JF, Webb MJ, Gaffey TA, Symmonds RE (1979). Stage I squamous cell cancer of the vulva. Am J Obstet Gynecol, 134, 453-9.
  15. Oonk MH, de Hullu JA, van der Zee AG (2010). Current controversies in the management of patients with early-stage vulvar cancer. Curr Opin Oncol, 22, 481-6. https://doi.org/10.1097/CCO.0b013e32833c06da
  16. Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG (1992). Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol, 45, 313-6. https://doi.org/10.1016/0090-8258(92)90311-6
  17. Paladini D, Cross P, Lopes A, Monaghan JM (1994). Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer, 74, 2491-6. https://doi.org/10.1002/1097-0142(19941101)74:9<2491::AID-CNCR2820740916>3.0.CO;2-5
  18. Podratz KC, Symmonds RE, Taylor WF, Williams TJ (1983). Carcinoma of the vulva: Analysis of treatment and survival. Obstet Gynecol, 61, 63-74.
  19. Rodolakis A, Diakomanolis E, Voulgaris Z, et al (2000). Squamous vulvar cancer: a clinically based individualization of treatment. Gynecol Oncol, 78, 346-51. https://doi.org/10.1006/gyno.2000.5882
  20. Sidor J, Diallo-Danebrock R, Eltze E, Lelle RJ (2006). Challenging the concept of microinvasive carcinoma of the vulva: report of a case with regional lymph node recurrence and review of the literature. BMC Cancer, 6, 157. https://doi.org/10.1186/1471-2407-6-157
  21. Van der Velden J, van Lindert AC, Lammes FB, et al (1995). Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer, 75, 2885-90. https://doi.org/10.1002/1097-0142(19950615)75:12<2885::AID-CNCR2820751215>3.0.CO;2-3
  22. Van der Zee AG, Oonk MH, De Hullu JA, et al (2008). Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol, 26, 884-9. https://doi.org/10.1200/JCO.2007.14.0566
  23. Woelber L, Mahner S, Voelker K, et al (2009). Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res, 29, 545-52.
  24. Woolderink JM, de Bock GH, de Hullu JA, et al (2006). Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol, 103, 293-9. https://doi.org/10.1016/j.ygyno.2006.03.010

Cited by

  1. Study of Biomolecular and Clinical Prognostic Factors in Patients With Cancer of the Vulva Undergoing Surgical Treatment vol.24, pp.4, 2014, https://doi.org/10.1097/IGC.0000000000000103
  2. Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva vol.124, pp.6, 2017, https://doi.org/10.1111/1471-0528.14560